Collaborative Evaluation of Optimal Antifungal Susceptibility Testing Conditions for Dermatophytes
Open Access
- 1 November 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (11) , 4121-4125
- https://doi.org/10.1128/jcm.40.11.3999-4003.2002
Abstract
Denaturing high-performance liquid chromatography (DHPLC) was evaluated as a rapid screening and identification method for DNA sequence variation detection in the quinolone resistance-determining region of gyrA from Salmonella serovars. A total of 203 isolates of Salmonella were screened using this method. DHPLC analysis of 14 isolates representing each type of novel or multiple mutations and the wild type were compared with LightCycler-based PCR-gyrA hybridization mutation assay (GAMA) and single-strand conformational polymorphism (SSCP) analyses. The 14 isolates gave seven different SSCP patterns, and LightCycler detected four different mutations. DHPLC detected 11 DNA sequence variants at eight different codons, including those detected by LightCycler or SSCP. One of these mutations was silent. Five isolates contained multiple mutations, and four of these could be distinguished from the composite sequence variants by their DHPLC profile. Seven novel mutations were identified at five different loci not previously described in quinolone-resistant salmonella. DHPLC analysis proved advantageous for the detection of novel and multiple mutations. DHPLC also provides a rapid, high-throughput alternative to LightCycler and SSCP for screening frequently occurring mutations.Keywords
This publication has 36 references indexed in Scilit:
- In Vitro Activity of Posaconazole against Clinical Isolates of DermatophytesJournal of Clinical Microbiology, 2001
- In Vitro Activities of 10 Antifungal Drugs against 508 Dermatophyte StrainsAntimicrobial Agents and Chemotherapy, 2001
- Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative EvaluationAntimicrobial Agents and Chemotherapy, 2001
- Comparison of the E-test with the NCCLS M38-P Method for Antifungal Susceptibility Testing of Common and Emerging Pathogenic Filamentous FungiJournal of Clinical Microbiology, 2001
- Comparison of In Vitro Activities of Voriconazole and Five Established Antifungal Agents against Different Species of Dermatophytes Using a Broth Macrodilution MethodJournal of Clinical Microbiology, 2001
- Pharmacokinetics of Antifungal Agents in OnychomycosesClinical Pharmacokinetics, 2001
- In vitro Susceptibility to Itraconazole, Clotrimazole, Ketoconazole and Terbinafine of 100 Isolates of Trichophyton rubrumChemotherapy, 2000
- In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvinMycoses, 1998
- Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infectionJournal of Antimicrobial Chemotherapy, 1997
- Deep dermatophytosis caused by Trichophyton rubrum in a patient with AIDSJournal of the American Academy of Dermatology, 1996